77MO A phase I trial of IMA203CD8, a PRAME-directed TCR T cell therapy in PRAME-positive solid tumors

Journal article

Peer reviewed

A. Busse, D.M. Araujo, L.F. Hernandez-Aya, A.M. Tsimberidou, K. Wetzko, D. Davar, T.A.W. Holderried, D. Jäger, A.J. Olszanski, S.P. Patel, …

Immuno-oncology technology, Vol.28, pp.101162-101162

2025-12

Files and links (1)

url

https://doi.org/10.1016/j.iotech.2025.101162View

Published (Version of record) Open

1 Record Views

Title: 77MO A phase I trial of IMA203CD8, a PRAME-directed TCR T cell therapy in PRAME-positive solid tumors
Creators: A. Busse
D.M. Araujo
L.F. Hernandez-Aya
A.M. Tsimberidou
K. Wetzko
D. Davar
T.A.W. Holderried
D. Jäger
A.J. Olszanski
S.P. Patel
E.M. Wagner-Drouet
T.P. Wang
A. Maia
S. Hengler
D. Krishna
A. Mayer-Mokler
D. Pankov
C.M. Britten
W. Alsdorf
M. Wermke
Publication Details: Immuno-oncology technology, Vol.28, pp.101162-101162
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032937800902976